Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 61871

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 16, 2012
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Teva Pharmaceuticals USA, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10

D-1409-2012
Recall number
D-1409-2012
Initiated
May 16, 2012
Classification
Class II
Status
Terminated
Quantity
2,268 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)

Code information

Lot #TE1Y261, Exp, 12/2013

Distribution pattern

Ohio